Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics

Connecticut Medicine

Volumn 63, Issue 8, 1999, Pages 455-457

  Landesman, Keith A ^b   Stozek, Michelle ^b   Freeman, Nancy J ^b  

^a BROWN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LANSOPRAZOLE; MACROLIDE; MEVINOLIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; DRUG SAFETY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HYPERLIPIDEMIA; MALE; RHABDOMYOLYSIS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTICHOLESTEREMIC AGENTS; ANTILIPEMIC AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; GEMFIBROZIL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; MALE; MIDDLE AGED; RHABDOMYOLYSIS;

EID: 0032846394     PISSN: 00106178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Tobert JA: Efficacy and long-term adverse effect pattern of lovastatin. Am J Cardiol 1988; 62:28J-34J.
2. Scandinavian simvastatin survival group: Randomized trial of cholesterol lowering in 4,444 patients with coronary artery disease. The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344:1383-9.
3. Pierce LR, Wysowski DK, Gross TP: Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. JAMA 1990; 264:71-6.
4. Goldman JA, Fishman AB, Lee JE, Johnson RJ: The role of cholersterol-lowering agents in drug-induced rhabdomyolysis and polymyositis. Arthritis Rheumat 1989; 32:358-59.
5. Kogan AD, Orenstein S: Lovastatin-induced acute rhabdomyolysis. Postgraduate Med J 1990; 66:294-6.
6. Marais GE, Larson KL: Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy. Ann Int Med 1990; 112:228-30.
7. Knoll RW, Ciafone R, Galen M: Rhabdomyolysis and renal failure secondary to combination therapy of hyperlipidemia with lovastatin and gemfibrozil. Conn Med 1993; 57593-4.
8. Naser UA, Abdul-Ghaffar, Mohammed RE: Pancreatitis and rhabdomyolysis associated with lovastatin-gemfibrozil therapy. J Clin Gastroenterol 1995; 21:340-1.
9. Van Puijenbroek EP, Du Buf-Vereijken PW, Spooren PF, Van Doormaal JJ: Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil. J Inter Med 1996; 240:403-4.
10. Tal A, Rajeshawari M, Isley W: Rhabdomyolysis associated with simvastatin-gemfibrozil therapy. Southern Medical J 1997; 90: 546-7.
11. Duell PB, Connor WE, Illingworth DR: Rhabdomyolysis after taking atorvastatin with gemfibrozil. Am J Cardiol 1998; 81: 368-9.
12. Corpier CL, Jones PH, Suki WN, et al: Rhabdomyolysis and renal injury with lovastatin use. JAMA 1988; 260:239-41.
13. Ayanian JZ, Fuchs CS, Stone RM: Lovastatin and rhabdomyolysis. Ann Inter Med 1988; 109:682-3.
14. Spach DH, Bauwens JE, Clark CD, Burke WG: Rhabdomyolysis associated with lovastatin and erythromycin use. Western J Med 1991;154:213-5.
15. Wong PW, Dillard TA, Kroenke K: Multiple organ toxicity from addition of erythromycin to long-term lovastatin therapy. Southern Medical J 1998; 91:202-5.
16. Gruden JW, Fisher KA: Lovastatin-induced rhabdomyolysis possibly associated with clarithromycin and azithromycin. Ann Pharmacother 1997; 31:859-63.